Treatment-emergent adverse events in dupilumab-treated patients with allergic diseases : A meta-analysis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:76 |
|---|---|
| Enthalten in: |
Allergy - 76(2021), 2 vom: 01. Feb., Seite 593-596 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chen, Xiaohong [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 14.05.2021 Date Revised 14.05.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/all.14610 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315881070 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315881070 | ||
| 003 | DE-627 | ||
| 005 | 20231225155853.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/all.14610 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1052.xml |
| 035 | |a (DE-627)NLM315881070 | ||
| 035 | |a (NLM)33017860 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chen, Xiaohong |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment-emergent adverse events in dupilumab-treated patients with allergic diseases |b A meta-analysis |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.05.2021 | ||
| 500 | |a Date Revised 14.05.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Meta-Analysis | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a ENT (rhinitis | |
| 650 | 4 | |a allergy treament | |
| 650 | 4 | |a asthma | |
| 650 | 4 | |a atopic dermatitis | |
| 650 | 4 | |a immunotherapy clinical | |
| 650 | 4 | |a nasal polyps…) | |
| 650 | 4 | |a sinusitis | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Interleukin-13 |2 NLM | |
| 650 | 7 | |a dupilumab |2 NLM | |
| 650 | 7 | |a 420K487FSG |2 NLM | |
| 700 | 1 | |a Liu, Menghui |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Shuo |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Zizhen |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Xia |e verfasserin |4 aut | |
| 700 | 1 | |a Lai, Xiaoping |e verfasserin |4 aut | |
| 700 | 1 | |a Bao, Hongwei |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Jiancong |e verfasserin |4 aut | |
| 700 | 1 | |a Chang, Lihong |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Gehua |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Allergy |d 1980 |g 76(2021), 2 vom: 01. Feb., Seite 593-596 |w (DE-627)NLM000313874 |x 1398-9995 |7 nnns |
| 773 | 1 | 8 | |g volume:76 |g year:2021 |g number:2 |g day:01 |g month:02 |g pages:593-596 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/all.14610 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 76 |j 2021 |e 2 |b 01 |c 02 |h 593-596 | ||